Co-Authors
This is a "connection" page, showing publications co-authored by Jifang Sheng and Qin Ning.
Connection Strength
0.150
-
Efficacy and Safety of All-oral, 12-week Ravidasvir Plus Ritonavir-boosted Danoprevir and Ribavirin in Treatment-naïve Noncirrhotic HCV Genotype 1 Patients: Results from a Phase 2/3 Clinical Trial in China. J Clin Transl Hepatol. 2019 Sep 28; 7(3):213-220.
Score: 0.053
-
Sustained serological and complete responses in HBeAg-positive patients treated with Peginterferon alfa-2b: a 6-year long-term follow-up of a multicenter, randomized, controlled trial in China. BMC Gastroenterol. 2019 May 02; 19(1):65.
Score: 0.051
-
Association of baseline vitamin D level with genetic determinants and virologic response in patients with chronic hepatitis B. Hepatol Res. 2018 Feb; 48(3):E213-E221.
Score: 0.046